Citation Impact
Citing Papers
Protein characterization of Saccharomyces cerevisiae RNA polymerase II after in vivo cross-linking
2007 StandoutNobel
Platelet gene expression and function in patients with COVID-19
2020 Standout
How cognitive and reactive fear circuits optimize escape decisions in humans
2018 StandoutNobel
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
2018 Standout
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Cardiac Complications in Patients With Community-Acquired Pneumonia
2012
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
2005 StandoutScience
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1
2008 StandoutScience
Beta‐lactam plus macrolides or beta‐lactam alone for community‐acquired pneumonia: A systematic review and meta‐analysis
2016
Outcomes of Early, Late, and No Admission to the Intensive Care Unit for Patients Hospitalized with Community‐acquired Pneumonia
2012
Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis
2012
Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis
2020
What is polypharmacy? A systematic review of definitions
2017 Standout
Liver fat, statin use, and incident diabetes: The Multi-Ethnic Study of Atherosclerosis
2015
Long-term Cognitive Impairment and Functional Disability Among Survivors of Severe Sepsis
2010 Standout
Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial
2016
Timing of Antibiotic Administration and Outcomes for Medicare Patients Hospitalized With Community-Acquired Pneumonia
2004
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
2020 Standout
Acute kidney injury
2012 Standout
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Influenza-Associated Hospitalizations in the United States
2004 Standout
Rheumatoid arthritis
2016 Standout
Burden and risk factors forPseudomonas aeruginosacommunity-acquired pneumonia: a multinational point prevalence study of hospitalised patients
2018
Empiric therapy directed against MRSA in patients admitted to the intensive care unit does not improve outcomes in community-acquired pneumonia
2012
Variation in Empiric Coverage Versus Detection of Methicillin-ResistantStaphylococcus aureusandPseudomonas aeruginosain Hospitalizations for Community-Onset Pneumonia Across 128 US Veterans Affairs Medical Centers
2017
Regulation of Telomere Elongation by the Cyclin-Dependent Kinase CDK1
2006 StandoutNobel
Predictors and Implications of Early Clinical Stability in Patients Hospitalized for Moderately Severe Community-Acquired Pneumonia
2016
Early Formation of mRNP
2003 StandoutNobel
Statins and Cataracts—a Visual Insight
2014
Relationships among initial hospital triage, disease progression and mortality in community‐acquired pneumonia
2012
Sepsis: pathophysiology and clinical management
2016
The impact of a delay in intensive care unit admission for community-acquired pneumonia
2010
SMART‐COP: A Tool for Predicting the Need for Intensive Respiratory or Vasopressor Support in Community‐Acquired Pneumonia
2008
Predicting risk of drug-resistant organisms in pneumonia: Moving beyond the HCAP model
2014
Validation of the Infectious Disease Society of America/American Thoracic Society 2007 guidelines for severe community-acquired pneumonia*
2009
Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
2004 Standout
Clinical Features Predicting Mortality Risk in Patients With Viral Pneumonia: The MuLBSTA Score
2019
Sepsis: a roadmap for future research
2015
Is the Present Definition of Health Care–Associated Pneumonia the Best Way to Define Risk of Infection with Antibiotic-Resistant Pathogens?
2012
Severe Sepsis and Septic Shock
2013 Standout
A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: A meta-analytic/meta-regression study
2010
New estimates of influenza-related pneumonia and influenza hospitalizations among the elderly
2004
Integrated Analysis of FOCUS 1 and FOCUS 2: Randomized, Doubled‐Blinded, Multicenter Phase 3 Trials of the Efficacy and Safety of Ceftaroline Fosamil versus Ceftriaxone in Patients with Community‐Acquired Pneumonia
2010
Inhaled Corticosteroids in Patients With Stable Chronic Obstructive Pulmonary Disease
2008
Conservation, Variability and the Modeling of Active Protein Kinases
2007 StandoutNobel
Healthcare-Associated Pneumonia Does Not Accurately Identify Potentially Resistant Pathogens: A Systematic Review and Meta-Analysis
2013
Impact of an Electronic Clinical Decision Support Tool for Emergency Department Patients With Pneumonia
2015
Acute kidney injury
2019 Standout
Incidence, Correlates, and Chest Radiographic Yield of New Lung Cancer Diagnosis in 3398 Patients With Pneumonia
2011
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis
2014
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
2020 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
2020 Standout
Crohn's disease
2016 Standout
JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects
2017
Sepsis and septic shock
2018 Standout
BTS guidelines for the management of community acquired pneumonia in adults: update 2009
2009
Characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease
2007
Snf1 kinase complexes with different beta subunits display stress-dependent preferences for the three Snf1-activating kinases
2005
Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia
2009
Targeting SOCS Proteins to Control JAK-STAT Signalling in Disease
2019
Cdk1-Dependent Phosphorylation of Cdc13 Coordinates Telomere Elongation during Cell-Cycle Progression
2009 StandoutNobel
How Important is Methicillin-Resistant Staphylococcus aureus as a Cause of Community-Acquired Pneumonia and What is Best Antimicrobial Therapy?
2012
Effect of antibiotic streamlining on patient outcome in pneumococcal bacteraemia
2014
Microbiology and outcomes of community acquired pneumonia in non cystic-fibrosis bronchiectasis patients
2015
The emerging safety profile of JAK inhibitors in rheumatic disease
2017
Targets of the cyclin-dependent kinase Cdk1
2003 Nature
Acute pneumonia and the cardiovascular system
2013
Cardiorenal Syndrome Type 1
2012
Community-Acquired Pneumonia Due to Multidrug- and Non–Multidrug-Resistant Pseudomonas aeruginosa
2016
The Role of Chromatin during Transcription
2007 Standout
The role of atherosclerosis in osteoarthritis
2017
Multiple levels of cyclin specificity in cell-cycle control
2007
Fluoroquinolones or macrolides in combination with β-lactams in adult patients hospitalized with community acquired pneumonia: a systematic review and meta-analysis
2016
Antiviral combinations for severe influenza
2014
Host-directed therapies for bacterial and viral infections
2017
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*
2006 Standout
Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia
2011
The Paf1 complex physically and functionally associates with transcription elongation factors in vivo
2002
Severity assessment tools to guide ICU admission in community-acquired pneumonia: systematic review and meta-analysis
2011
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
2010 Standout
Cell cycle, CDKs and cancer: a changing paradigm
2009 Standout
Phosphorylation of Chs2p regulates interaction with COPII
2013 StandoutNobel
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis with over 2 Years Median Time in Treatment
2018
Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study
2017
The immunopathology of sepsis and potential therapeutic targets
2017 Standout
Validation and clinical implications of the IDSA/ATS minor criteria for severe community-acquired pneumonia
2009
Real-world comparative risks of herpes virus infections in tofacitinib and biologic-treated patients with rheumatoid arthritis
2016
The Artificial Intelligence Clinician learns optimal treatment strategies for sepsis in intensive care
2018 Standout
Macrolides and Mortality in Critically Ill Patients With Community-Acquired Pneumonia
2013
Long-term outcomes from sepsis
2007
Clinical evaluation of the need for carbapenems to treat community-acquired and healthcare-associated pneumonia
2015
Defining trained immunity and its role in health and disease
2020 Standout
In Vivo Platelet Activation in Critically Ill Patients With Primary 2009 Influenza A(H1N1)
2012
Trends in Antibiotic Use and Nosocomial Pathogens in Hospitalized Veterans With Pneumonia at 128 Medical Centers, 2006–2010
2015
Osteoarthritis
2019 Standout
Prospective, randomised study to compare empirical treatment versus targeted treatment on the basis of the urine antigen results in hospitalised patients with community-acquired pneumonia
2009
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Validation of the Infectious Diseases Society of America/American Thoratic Society Minor Criteria for Intensive Care Unit Admission in Community-Acquired Pneumonia Patients Without Major Criteria or Contraindications to Intensive Care Unit Care
2011
Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza
2012
Statins Associated With Decreased Risk of New Onset Inflammatory Bowel Disease
2016
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Impact of guideline-concordant microbiological testing on outcomes of pneumonia
2013
The ecology of human fear: survival optimization and the nervous system
2015
Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial
2014
The Yeast Tor Signaling Pathway Is Involved in G2/M Transition via Polo-Kinase
2008 StandoutNobel
Adherence to guidelines for hospitalized community-acquired pneumonia over time and its impact on health outcomes and mortality
2016
Community-Acquired Pneumonia
2014
A comparison between time to clinical stability in community-acquired aspiration pneumonia and community-acquired pneumonia
2012
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
2019 Standout
Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations
2015 Standout
Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia
2006
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Assessment of Clinical Criteria for Sepsis
2016 Standout
Antibiotic Therapy for Adults Hospitalized With Community-Acquired Pneumonia
2016
The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
2015
Derivation and Multicenter Validation of the Drug Resistance in Pneumonia Clinical Prediction Score
2016
Healthcare‐associated pneumonia: A US disease or relevant to the A sia P acific, too?
2013
Independent modulation of the kinase and polo-box activities of Cdc5 protein unravels unique roles in the maintenance of genome stability
2011
Outcomes of Health Care–Associated Pneumonia Empirically Treated with Guideline-Concordant Regimens Versus Community-Acquired Pneumonia Guideline–Concordant Regimens for Patients Admitted to Acute Care Wards from Home
2013
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Dual Roles for Spt5 in Pre-mRNA Processing and Transcription Elongation Revealed by Identification of Spt5-Associated Proteins
2003
Outcome of Recommendations for Radiographic Follow-Up of Pneumonia on Outpatient Chest Radiography
2013
Regulation of the Cell Cycle by Protein Phosphatase 2A in Saccharomyces cerevisiae
2006
Association of guideline-based antimicrobial therapy and outcomes in healthcare-associated pneumonia
2015
Effect of Corticosteroids on Treatment Failure Among Hospitalized Patients With Severe Community-Acquired Pneumonia and High Inflammatory Response
2015
Is post‐pneumonia chest X ‐ray for lung malignancy useful? Results of an audit of current practice
2015
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseases
2020
Guideline-Concordant Treatment of Kawasaki Disease With Immunoglobulin and Aspirin and the Incidence of Coronary Artery Aneurysm
2015
Cataracts
2017 Standout
COVID-19 and its implications for thrombosis and anticoagulation
2020 Standout
β-Lactam Monotherapy vs β-Lactam–Macrolide Combination Treatment in Moderately Severe Community-Acquired Pneumonia
2014
The respiratory threat posed by multidrug resistant G ram‐negative bacteria
2017
A Randomized, Double‐Blind, Placebo‐Controlled, Twelve‐Week, Dose‐Ranging Study of Decernotinib, an Oral Selective JAK‐3 Inhibitor, as Monotherapy in Patients With Active Rheumatoid Arthritis
2014
Efficacy and Safety of Nemonoxacin versus Levofloxacin for Community-Acquired Pneumonia
2010
Omadacycline for Community-Acquired Bacterial Pneumonia
2019
Acute Infection and Myocardial Infarction
2019
VX‐509 (Decernotinib), an Oral Selective JAK‐3 Inhibitor, in Combination With Methotrexate in Patients With Rheumatoid Arthritis
2015
Tor Kinases Are in Distinct Membrane-associated Protein Complexes inSaccharomyces cerevisiae
2003
JAK inhibitors for alopecia areata: a systematic review and meta‐analysis
2019
Works of Eric M. Mortensen being referenced
Causes of Death for Patients With Community-Acquired Pneumonia—Reply
2002
The impact of prior outpatient ACE inhibitor use on 30-day mortality for patients hospitalized with community-acquired pneumonia
2005
Association of Hydrophilic Versus Lipophilic Angiotensin-Converting Enzyme Inhibitor Use on Pneumonia-Related Mortality
2008
Cdc28-Dependent Regulation of the Cdc5/Polo Kinase
2005
Statins and Musculoskeletal Conditions, Arthropathies, and Injuries
2013
Comparison of two guideline-concordant antimicrobial combinations in elderly patients hospitalized with severe community-acquired pneumonia*
2012
Incidence of Musculoskeletal and Neoplastic Diseases in Patients on Statin Therapy: Results of a Retrospective Cohort Analysis
2012
A clinical pathway for community-acquired pneumonia: an observational cohort study
2011
Impact of Previous Statin and Angiotensin II Receptor Blocker Use on Mortality in Patients Hospitalized with Sepsis
2007
Incidence of Cardiovascular Events After Hospital Admission for Pneumonia
2011
Monotherapy versus combination antibiotic therapy for patients with bacteremic Streptococcus pneumoniae community-acquired pneumonia
2007
Pulmonary disease among inpatient decedents: Impact of schizophrenia
2007
Statins and New-Onset Diabetes Mellitus and Diabetic Complications: A Retrospective Cohort Study of US Healthy Adults
2015
Association of Statin Use With Cataracts
2013
The controversy of a wider statin utilization: why?
2013
Inhaled corticosteroid use is associated with lower mortality for subjects with COPD and hospitalised with pneumonia
2010
Causes of Death for Patients With Community-Acquired Pneumonia
2002
Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia
2004
Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia
2007
Population-Based Study of Statins, Angiotensin II Receptor Blockers, and Angiotensin-Converting Enzyme Inhibitors on Pneumonia-Related Outcomes
2012
Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit
2010
Severe community-acquired pneumonia: current outcomes, epidemiology, etiology, and therapy
2001
Treatment Failure and Costs in Patients With Methicillin-Resistant Staphylococcus aureus (MRSA) Skin and Soft Tissue Infections: A South Texas Ambulatory Research Network (STARNet) Study
2013
Assessment of Mortality after Long-Term Follow-Up of Patients with Community-Acquired Pneumonia
2003
Predictors of Long-term Mortality After Severe Sepsis in the Elderly
2013
Late Admission to the ICU in Patients With Community-Acquired Pneumonia Is Associated With Higher Mortality
2009
Diagnosis of Pulmonary Malignancy after Hospitalization for Pneumonia
2009
Comparison of Frequency of Inflammatory Bowel Disease and Noninfectious Gastroenteritis Among Statin Users Versus Nonusers
2015
Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia
2008
Guideline-concordant therapy and outcomes in healthcare-associated pneumonia
2011
Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis
2015
Causes and Risk Factors for Rehospitalization of Patients Hospitalized with Community-Acquired Pneumonia
2008
Health care–associated pneumonia in the intensive care unit: Guideline-concordant antibiotics and outcomes
2016
A Comparative Study of Community-Acquired Pneumonia Patients Admitted to the Ward and the ICU
2007
COPD is associated with increased mortality in patients with community-acquired pneumonia
2006
Impact of Guideline-Concordant Empiric Antibiotic Therapy in Community-Acquired Pneumonia
2006
Observational Study of Inhaled Corticosteroids on Outcomes for COPD Patients with Pneumonia
2011
Association of Azithromycin With Mortality and Cardiovascular Events Among Older Patients Hospitalized With Pneumonia
2014
Predictors of P seudomonas and methicillin‐resistant S taphylococcus aureus in hospitalized patients with healthcare‐associated pneumonia
2015
Cell Cycle-dependent Assembly of a Gin4-Septin Complex
2002
The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia
2005
Herpes Zoster and Tofacitinib Therapy in Patients With Rheumatoid Arthritis
2014
Risk factors and antibiotic therapy in P . aeruginosa community‐acquired pneumonia
2015
Association of Suboptimal Prescribing and Change in Lower Extremity Physical Function over Time
2007